Antibodies against B7-DC with differential binding properties exert opposite effects

Hybridoma

Volumn 31, Issue 1, 2012, Pages 40-47

  Ritprajak, Patcharee ^a,c   Hashiguchi, Masaaki ^a   Akiba, Hisaya ^b   Yagita, Hideo ^b   Okumura, Ko ^b   Azuma, Miyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

MIH37 ANTIBODY; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 LIGAND 2; PROGRAMMED DEATH 1 RECEPTOR; TY25 ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGENS, CD274; DERMATITIS, CONTACT; FLOW CYTOMETRY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; PERIPHERAL TOLERANCE; PROGRAMMED CELL DEATH 1 LIGAND 2 PROTEIN; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTEIN BINDING;

MUS;

EID: 84856929908     PISSN: 15540014     EISSN: 15578348     Source Type: Journal    
DOI: 10.1089/hyb.2011.0087     Document Type: Article

References (41)

1. Sharpe AH, and Freeman GJ: The B7-CD28 superfamily. Nat Rev Immunol 2002;2:116-126. (Pubitemid 37323235)
2. Chen L: Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004; 4:336-347. (Pubitemid 38649276)
3. Keir ME, Butte MJ, Freeman GJ, and Sharpe AH: PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008;26:677-704. (Pubitemid 351600389)
4. Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K, Azuma M, and Yagita H: Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002;169:5538-5545. (Pubitemid 35291652)
5. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, and Freeman GJ: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001;2:261-268. (Pubitemid 33706004)
6. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM, and Tsuchiya H: B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001;193:839-846.
7. Greenwald RJ, Freeman GJ, and Sharpe AH: The B7 family revisited. Annu Rev Immunol 2005;23:515-548. (Pubitemid 40563179)
8. + T cells and is overcome by IL-2. Eur J Immunol 2002;32:634-643. (Pubitemid 34257540)
9. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, Yamazaki T, Akiba H, Yagita H, Takahashi Y, Omura K, Okumura K, and Azuma M: Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 2003;33: 2773-2782. (Pubitemid 37337143)
10. Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Au-chincloss H Jr, and Sayegh MH: The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 2003;198:63-69. (Pubitemid 36870186)
11. Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, and Bluestone JA: Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J Exp Med 2006;203:2737-2747. (Pubitemid 44833349)
12. Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H
13. Azuma M, Atkinson M, Bluestone JA, and Sayegh MH: Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin Immunol 2007;125:16-25. (Pubitemid 47376921)
14. Aramaki O, Shirasugi N, Takayama T, Shimazu M, Kitajima M, Ikeda Y, Azuma M, Okumura K, Yagita H, and Niimi M: Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation 2004;77:6-12. (Pubitemid 38116864)
15. Sandner SE, Clarkson MR, Salama AD, Sanchez-Fueyo A, Domenig C, Habicht A, Najafian N, Yagita H, Azuma M, Turka LA, and Sayegh MH: Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 2005;174:3408-3415. (Pubitemid 40354046)
16. Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, and Najafian N: Analysis of the role of negative T cell costimu-latory pathways in CD4 and CD8 T cell-mediated allo-immune responses in vivo. J Immunol 2005;174:6648-6656. (Pubitemid 40705625)
17. + regulatory T-cell activity to suppress alloimmune responses. Transplantation 2007;83:774-782. (Pubitemid 46569197)
18. Koga N, Suzuki J, Kosuge H, Haraguchi G, Onai Y, Futa-matsu H, Maejima Y, Gotoh R, Saiki H, Tsushima F, Azuma M, and Isobe M: Blockade of the interaction between PD-1 and PD-L1 accelerates graft arterial disease in cardiac allo-grafts. Arterioscler Thromb Vasc Biol 2004;24:2057-2062. (Pubitemid 39482430)
19. Tanaka K, Albin MJ, Yuan X, Yamaura K, Habicht A, Murayama T, Grimm M, Waaga AM, Ueno T, Padera RF, Yagita H, Azuma M, Shin T, Blazar BR, Rothstein DM, Sayegh MH, and Najafian N: PDL1 is required for peripheral transplantation tolerance and protection from chronic allo-graft rejection. J Immunol 2007;179:5204-5210.
20. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H, Noelle RJ, Coyle A, Mellor AL, Khoury SJ, and Sayegh MH: A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005;202:231-237. (Pubitemid 41043819)
21. Habicht A, Dada S, Jurewicz M, Fife BT, Yagita H, Azuma M, Sayegh MH, and Guleria I: A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol 2007; 179:5211-5219.
22. Matsumoto K, Inoue H, Nakano T, Tsuda M, Yoshiura Y, Fukuyama S, Tsushima F, Hoshino T, Aizawa H, Akiba H, Pardoll D, Hara N, Yagita H, Azuma M, and Nakanishi Y: B7-DC regulates asthmatic response by an IFN-g-dependent mechanism. J Immunol 2004;172:2530-2541. (Pubitemid 38182404)
23. Fukushima A, Yamaguchi T, Azuma M, Yagita H, and Ueno H: Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice. Br J Ophthalmol 2006;90:1040-1045. (Pubitemid 44140189)
24. Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, and Khoury SJ: Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyeli-tis. J Exp Med 2003;198:71-78. (Pubitemid 36870187)
25. Zhu B, Guleria I, Khosroshahi A, Chitnis T, Imitola J, Azuma M, Yagita H, Sayegh MH, and Khoury SJ: Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis. J Immunol 2006; 176:3480-3489. (Pubitemid 43363995)
26. + T cells in vivo. Am J Transplant 2007;7:2683-2692. (Pubitemid 350045774)
27. Ishiwata K, Watanabe N, Guo M, Tomihara K, Brumlik MJ, Yagita H, Pardoll D, Chen L, and Shin T: Costimulator B7-DC attenuates strong Th2 responses induced by Nippo-strongylus brasiliensis. J Immunol 2010;184:2086-2094.
28. Liu X, Gao JX, Wen J, Yin L, Li O, Zuo T, Gajewski TF, Fu YX, Zheng P, and Liu Y: B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. J Exp Med 2003;197:1721-1730. (Pubitemid 36745347)
29. + T cells independent of the PD-1 receptor. J Exp Med 2003;198:31-38. (Pubitemid 36870183)
30. Shin T, Yoshimura K, Crafton EB, Tsuchiya H, Housseau F, Koseki H, Schulick RD, Chen L, and Pardoll DM: In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses. J Exp Med 2005;201:1531-1541. (Pubitemid 40720999)
31. Wang S, Bajorath J, Flies DB, Dong H, Honjo T, and Chen L: Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J Exp Med 2003;197:1083-1091. (Pubitemid 36570064)
32. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, and Honjo T: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-322. (Pubitemid 32096320)
33. Hashiguchi M, Kobori H, Ritprajak P, Kamimura Y, Kozono H, and Azuma M: Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proc Natl Acad Sci USA 2008;105:10495-10500.
34. Youngnak P, Kozono Y, Kozono H, Iwai H, Otsuki N, Jin H, Omura K, Yagita H, Pardoll DM, Chen L, and Azuma M: Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 2003;307: 672-677. (Pubitemid 36944985)
35. + T cell proliferation by augmenting IFN-g-induced nitric oxide production. J Immunol 2005;175:1586-1592. (Pubitemid 41023060)
36. Kamimura Y, Iwai H, Piao J, Hashiguchi M, and Azuma M: The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity. J Immunol 2009;182:2708-2716.
37. Ghiotto M, Gauthier L, Serriari N, Pastor S, Truneh A, Nunes JA, and Olive D: PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int Immunol 2010;22:651-660.
38. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, and Freeman GJ: Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007;27:111-122. (Pubitemid 47089023)
39. Pentcheva-Hoang T, Egen JG, Wojnoonski K, and Allison JP: B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004;21:401-413. (Pubitemid 39208341)
40. Pentcheva-Hoang T, Chen L, Pardoll DM, and Allison JP: Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability. Proc Natl Acad Sci USA 2007;104:17765-17770. (Pubitemid 350210909)
41. Saito T, Yokosuka T, and Hashimoto-Tane A: Dynamic regulation of T cell activation and co-stimulation through TCR-microclusters. FEBS Lett 2010;584:4865-4871.